About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Hybrid Model of Vocal Inflammation and Tissue Mobilization

NCT01197339·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Pittsburgh

With

National Institute on Deafness and Other Communication Disorders (NIDCD)
McGill University
Purdue University

Age

18–40

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

healthy females
ages 18-40
generally healthy
normal hearing bilaterally at 20 dB to 8,000 Hz
have ability to produce "resonant voice" during training as determined by the examiner perceptually
Tolerate rigid and nasal endoscopy without anesthesia to the larynx nasal patency allowing for the passage of an endoscope unilaterally

You may not be if

Smoking within the past five yr
Failing a hearing screening test
Having current chronic voice problems
Having current medications that are determined to possibly influence voice
Having heightened gag reflex
Having known or suspected allergy to anesthetics
Pregnancy reported

The record

StatusCompleted

PhasePhase 1

Taking part45

StartedSep 2010

UpdatedJan 25, 2016

Conditions

Acute Phonotrauma

Where1

Univesity of Pittsburgh
Pittsburgh, Pennsylvania, United States

Clareo Health | Hybrid Model of Vocal Inflammation and Tissue Mobilization